RecruitingNCT07608822

BIO|STREAM.CSP CLS

Observation of Clinical Routine Care for Patients Implanted With BIOTRONIK Devices Used for Conduction System Pacing (CSP) With Focus on Closed Loop Stimulation (CLS)


Sponsor

Biotronik SE & Co. KG

Enrollment

150 participants

Start Date

May 29, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This clinical study is a prospective, observational submodule of the BIO\|STREAM.CSP registry designed to evaluate clinical outcomes in patients receiving BIOTRONIK dual-chamber pacemakers that combine conduction system pacing-specifically left bundle branch area pacing (LBBAP)-with Closed Loop Stimulation (CLS). The purpose of the study is to better understand how this combined pacing strategy performs in routine clinical practice and whether it may help reduce the occurrence of atrial fibrillation in patients with sinus node dysfunction (SND) and concomitant atrioventricular (AV) conduction disorders. The primary question the study seeks to answer is what the incidence of device-detected atrial fibrillation (DDAF) is over a 24-month follow-up period in patients treated with LBBAP and active CLS. Additionally, the study explores how CLS dynamically modulates pacing rates when the ventricular lead is positioned within the conduction system, and whether this physiological pacing approach may mitigate the negative effects associated with conventional right ventricular pacing. Overall, this study aims to generate real-world evidence to support optimization of pacemaker programming and to inform clinical decision-making regarding the use of CLS in combination with conduction system pacing, with the goal of improving patient outcomes and reducing atrial arrhythmia burden.


Eligibility

Min Age: 18 YearsMax Age: 18 Years

Inclusion Criteria4

  • Enrolled in the BIO\|STREAM.CSP registry
  • Standard indication for dual-chamber pacing due to any form of sinus node disease according to guidelines
  • DDD-CLS pacing mode activated
  • Either ≥ II degree AV block, or native PR interval ≥ 200 ms at baseline ECG with expected RVP ≥ 20%

Exclusion Criteria6

  • Implantation dates back more than 90 days
  • History of clinical AF
  • Patients intended to receive, or already received a pacing lead for traditional RV pacing, His bundle pacing or right bundle branch pacing
  • Upgrade from previous pacemaker system
  • Patients transitioning from the BIO\|MASTER.CSP study
  • DDAF episodes present in the device memory at the time of registration

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELeft bundle branch area pacing with Closed Loop Stimulation

Permanent dual-chamber cardiac pacing with ventricular lead placement in the left bundle branch area and activation of the Closed Loop Stimulation (CLS) rate-responsive algorithm.


Locations(12)

Masarykova nemocnice v Usti nad Labem

Ústí nad Labem, Czechia

Semmelweis University

Budapest, Hungary

University of Szeged

Szeged, Hungary

Ospedale Di Summa - Perrino

Brindisi, Italy

Niguarda hospital

Milan, Italy

A.O.U. Maggiore della Carita di Novara

Novara, Italy

Ospedale di Piove di Sacco

Piove di Sacco, Italy

Fondazione Policlinico Universitario "Agostino Gemelli" Università Cattolica del Sacro Cuore

Roma, Italy

SS Annunziata Taranto

Taranto, Italy

Unidade local de Saúde de Coimbra, EPE - Centro Hospitalar Universitario de Coimbra

Coimbra, Portugal

Hospital Universitario 12 de Octubre

Madrid, Spain

Hospital Universitario La Fe

Valencia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07608822


Related Trials